Aerovate Therapeutics Inc.

NASDAQ: AVTE
Share price (3/25/25): $2.51
Market cap (3/25/25): $72.5 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Business combination disclosure

Prospectus supplement

Details of business combination or exchange offer – amended

Details of business combination or exchange offer – amended

Business combination disclosure

Ownership Filter

Baker Bros. Advisors LP

Dake Benjamin T

RA Capital Healthcare Fund LP, Ra Capital Management, L.P., Kolchinsky Peter, Shah Rajeev M., RA Capital Nexus Fund, L.P.

Ra Capital Management, L.P.

Verwijs Marinus

News Filter

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

To Explore Strategic Alternatives

Cost of Exit or Disposal Activities

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness